首页> 外文期刊>Oncology and Therapy >Value Added Impact of Both Point-of-Care and Laboratory Lactic Acid Analysis When Emergently Evaluating Cancer Patients
【24h】

Value Added Impact of Both Point-of-Care and Laboratory Lactic Acid Analysis When Emergently Evaluating Cancer Patients

机译:在急诊评价癌症患者时,对护理点和实验室乳酸分析的增值额外影响

获取原文
       

摘要

INTRODUCTION:Cancer patients are immunosuppressed and may present to an emergency department with atypical symptoms. In the emergency setting, it is important ascertain rapidly if lactic acid levels are high, either due to sepsis or tumor lysis syndrome, to effectively manage symptoms. Therefore, it is critical to determine the blood lactic acid level to timely identify who is at risk of sepsis and provide early intervention. We have compared blood lactic acid concentrations (BLAC) in cancer patients obtained by point-of-care testing (POCT) and those measured by laboratory analysis in blood samples drawn within a short time of each other.METHODS:This was a retrospective study in cancer patients whose BLAC had been determined by POCT and laboratory analysis. Only those patients who had blood withdrawn for both testing methods within a 2-h timeframe were included in the study. Regressions were performed together with an analysis categorizing the BLAC from both testing methods.RESULTS:A total of 274 patients met the criteria for the study. The BLAC from POCT correlated well with the values from laboratory testing (R?=?0.925). Categorization of BLAC showed that 88.32% of the patients had BLAC that directly matched between the two tests; 28 (10.22%) patients had a normal BLAC according to laboratory analysis but a high BLAC on POCT; and four (1.46%) patients had a high BLAC according laboratory analysis but normal BLAC on POCT.CONCLUSIONS:There was a high correlation between POCT and laboratory analysis values of BLAC in cancer patients, with the results from both testing methods agreeing 96% of the time. This finding suggests that POCT would suffice in most cases. Importantly, in 2% of the cancer patients who presented emergently, BLAC determined by POCT and laboratory analysis did not agree. Therefore, in subsequent decision-making, we recommend that if sepsis is suspected and BLAC determined by POCT is normal, nucleic acids, proteins, circulating cells, and interleukin-3 levels should also be obtained by POCT to confirm sepsis and/or rule out tumor lysis syndrome in patients with cancer.
机译:介绍:癌症患者是免疫抑制的,可能出现在急诊部门的症状。在紧急情况下,如果乳酸水平很高,则迅速确定,由于败血症或肿瘤裂解综合征,有效地管理症状。因此,确定血液乳酸水平至关重要,以及时识别患有败血症的风险并提供早期干预。我们已经比较了通过护理点测试(POCT)获得的癌症患者中的血液乳酸浓度(BLAC),并通过在彼此短时间内绘制的血液样本中的实验室分析测量的那些。方法:这是回顾性研究癌症患者,其BLAC已经通过POCT和实验室分析确定。只有那些患有血液以在2-H时框架内撤销的血液的患者才包括在研究中。回归与对测试方法分类的分析一起进行。结果:共有274名患者达到了该研究的标准。来自POCT的BLAC与实验室测试的值良好相关(R?= 0.925)。 BLAC的分类表明,88.32%的患者的BLAC直接匹配两次测试; 28(10.22%)患者根据实验室分析,患者具有正常的BLAC,但在POCT上是高的BLAC; 4例(1.46%)患者在实验室分析中具有高的BLAC,但在POCT.Concluctions上进行正常的BLAC:POCT与实验室分析值与癌症患者的BLAC之间存在高的相关性,结果来自两种测试方法的结果达成96%时间。这一发现表明,在大多数情况下,POCT就足够了。重要的是,在2%的癌症患者中,由POCT和实验室分析确定的BLAC并不同意。因此,在随后的决策中,我们建议,如果怀疑败血症并且通过POCT确定的BLAC是正常的,核酸,蛋白质,循环细胞和白细胞介素-3水平也应该通过POCT来确认败血症和/或排除癌症患者肿瘤裂解综合征。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号